Epic Update : Sun Pharmaceutical

Sun Pharmaceutical Industries and its subsidiaries, Sun Pharma has entered into a definitive agreement with DUSA Pharmaceuticals, Inc.  Under this agreement Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan (aminolevulinic acid HCl) photodynamic therapy platform.
Get Free MCX Tips, Stock Tips, Forex Tips & NCDEX Tips,Commodity Tips, Share Tips, commodity tips free trial, nifty free tips, commodity trading tips, shares tips, Share Market Tips, Stock Market Tips, free stock tips on mobile, Stock trading tips, Intraday Tips.